Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuta Tomida

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Cancer Science|October 6, 2018
Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiationChiemi Nakayama, Nobutake Yamamichi, Shuta Tomida, et al.
Anticancer Research|May 6, 2020
Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic <i>BRAF</i> MutationShunsaku Miyauchi, Kazuhiko Shien, Tatsuaki Takeda, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve <i>Egfr</i>-Mutant Lung Cancer with Non-Inflamed Tumor MicroenvironmentAtsuko Hirabae, Tadahiro Kuribayashi, Shuta Tomida, et al.
Molecular Carcinogenesis|February 27, 2016
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapiesTakuro Mizukami, Yosuke Togashi, Saeko Naruki, et al.
The Journal of Investigative Dermatology|January 23, 2013
Propionibacterium acnes strain populations in the human skin microbiome associated with acneSorel Fitz-Gibbon, Shuta Tomida, Bor-Han Chiu, et al.
Cancer Science|July 28, 2018
Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusionsYuka Kato, Kiichiro Ninomiya, Kadoaki Ohashi, et al.
Respiratory Research|February 8, 2022
Identification of targetable kinases in idiopathic pulmonary fibrosisHisao Higo, Kadoaki Ohashi, Shuta Tomida, et al.
Cancer Science|May 2, 2021
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulationHanxiao Shi, Atsuko Niimi, Toshiyuki Takeuchi, et al.
JTO Clinical and Research Reports|August 9, 2022
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLCHiroaki Kanemura, Hidetoshi Hayashi, Shuta Tomida, et al.
Journal of Gastroenterology|January 16, 2022
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potentialChihiro Takeuchi, Junichi Sato, Satoshi Yamashita, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Cancer Science|October 6, 2018
Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiationChiemi Nakayama, Nobutake Yamamichi, Shuta Tomida, et al.
Anticancer Research|May 6, 2020
Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic <i>BRAF</i> MutationShunsaku Miyauchi, Kazuhiko Shien, Tatsuaki Takeda, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve <i>Egfr</i>-Mutant Lung Cancer with Non-Inflamed Tumor MicroenvironmentAtsuko Hirabae, Tadahiro Kuribayashi, Shuta Tomida, et al.
Molecular Carcinogenesis|February 27, 2016
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapiesTakuro Mizukami, Yosuke Togashi, Saeko Naruki, et al.
The Journal of Investigative Dermatology|January 23, 2013
Propionibacterium acnes strain populations in the human skin microbiome associated with acneSorel Fitz-Gibbon, Shuta Tomida, Bor-Han Chiu, et al.
Cancer Science|July 28, 2018
Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusionsYuka Kato, Kiichiro Ninomiya, Kadoaki Ohashi, et al.
Respiratory Research|February 8, 2022
Identification of targetable kinases in idiopathic pulmonary fibrosisHisao Higo, Kadoaki Ohashi, Shuta Tomida, et al.
Cancer Science|May 2, 2021
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulationHanxiao Shi, Atsuko Niimi, Toshiyuki Takeuchi, et al.
JTO Clinical and Research Reports|August 9, 2022
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLCHiroaki Kanemura, Hidetoshi Hayashi, Shuta Tomida, et al.
Journal of Gastroenterology|January 16, 2022
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potentialChihiro Takeuchi, Junichi Sato, Satoshi Yamashita, et al.
Pageof 17